Efficacy of erdosteine, carbocysteine, and N-acetylcysteine in COPD: a comparative analysis Source: International Congress 2019 – Treatment of airway diseases in primary care Year: 2019
Persistency of antioxidant/antiinflammatory effects of erdosteine treatment in COPD Source: Annual Congress 2009 - Drug effects in COPD Year: 2009
Anti-inflammatory therapies in bronchiectasis Source: Eur Respir Mon 2011; 52: 223-238 Year: 2011
Pharmacological agents used to treat asthma Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=339 Year: 2003
Inhalations of ultra-low doses of alkylating drug for the treatment of steroid-dependant asthma: anti-inflammatory effect of therapy Source: Eur Respir J 2001; 18: Suppl. 33, 266s Year: 2001
Anti-asthmatic drugs: treatment of athletes and exercise-induced bronchoconstriction Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-22-7, page=73 Year: 2005
Macrolides, mucoactive drugs and adherence for the management of bronchiectasis Source: Eur Respir J, 51 (1) 1702033; 10.1183/13993003.02033-2017 Year: 2018
Macrolides, mucoactive drugs and adherence for the management of bronchiectasis Source: Eur Respir J, 51 (1) 1701987; 10.1183/13993003.01987-2017 Year: 2018
Tolerance of two cox2 - inhibitors, rofecoxib and celecoxib, in aspirin sensitive asthmatics Source: Eur Respir J 2001; 18: Suppl. 33, 428s Year: 2001
Single-dose desloratadine and montelukast and allergen-induced late airway responses Source: Eur Respir J 2009; 33: 1302-1308 Year: 2009
The inhibitory effect of salbutamol on neutrophil's respiratory burst is enhanced by the SH-metabolite of erdosteine (mucoactive drug) Source: Eur Respir J 2002; 20: Suppl. 38, 617s Year: 2002
The inhibitory effect of ciprofloxacin on bacterial adhesiveness is enhanced by the SH-metabolite I of erdosteine (mucolytic drug) Source: Eur Respir J 2001; 18: Suppl. 33, 543s Year: 2001
Anti-inflammatory effects of high-dose inhaled fluticasone versus oral prednisone in asthma exacerbations Source: Eur Respir J 2007; 30: 1143-1149 Year: 2007
Anti-inflammatory effects of formoterol and fluticasone propionate in bronchial epithelial cells Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015
Mucoactive therapy in COPD Source: Eur Respir Rev 2009; 19: 134-140 Year: 2010
Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis Source: Eur Respir J 2002; 19: 294-302 Year: 2002
Long-term use of antioxidant mucolytic erdosteine is especially beneficial in patients with more severe COPD Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008
Emerging inhaled bronchodilators: an update Source: Eur Respir J 2009; 34: 757 Year: 2009
RPL554, an inhaled PDE3/4 inhibitor, causes comparable bronchodilation to high dose nebulised salbutamol in asthmatics with fewer systemic effects Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016
Mucolytics and anti-inflammatory lung treatments Source: ERS course 2015 Year: 2015